🔗 Permalink

Inventor profile of:

Mitchell S. Steiner

City:

Germantown, Tennessee

Country:

United States

Published Applications:

Last publication date:

2026-05-21

Top Assignees for applications by Mitchell S. Steiner

The entities that hold a legal rights for patent applications filed by inventor Steiner Mitchell S.:

VERU INC 15 MIAMI, FL United States
GTx, Inc. 13 Memphis, TN United States
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 13 Knoxville, TN United States
Gtx 2 Memphis, TN United States
Otx, Inc. 1 Memphis, TN United States
UN IVERSITY OF TENNESSEE RESEARCH FOUNDATION 1 KNOXVILLE, TN United States
Oncternal Therapeutics, Inc. 1 San Diego, CA United States

Recent patent applications by Steiner Mitchell S.

Mitchell S. Steiner from Germantown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-21

US20260137648A1

Human necessities

COMPOSITIONS COMPRISING SELECTIVE ANDROGEN RECEPTOR MODULATOR COMPOUNDS IN COMBINATION WITH WEIGHT LOSS DRUGS AND USES THEREOF FOR INCREMENTAL WEIGHT LOSS AND MANAGEMENT OF ADVERSE SIDE EFFECTS OF WEIGHT LOSS DRUGS ON BODY COMPOSITION

#2 | 2026-03-12

US20260069564A1

Human necessities

COMPOSITIONS COMPRISING SELECTIVE ANDROGEN RECEPTOR MODULATOR COMPOUNDS IN COMBINATION WITH WEIGHT LOSS DRUGS AND USES THEREOF FOR QUALITY WEIGHT LOSS

#3 | 2026-02-26

US20260053769A1

Human necessities

USES OF SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) COMPOUNDS FOR QUALITY WEIGHT LOSS

#4 | 2026-01-08

US20260007630A1

Human necessities

COMPOSITIONS COMPRISING SELECTIVE ANDROGEN RECEPTOR MODULATOR COMPOUNDS IN COMBINATION WITH WEIGHT LOSS DRUGS AND USES THEREOF FOR QUALITY WEIGHT LOSS

#5 | 2025-07-17

US20250228804A1

Human necessities

USES OF SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) COMPOUNDS FOR QUALITY WEIGHT LOSS

#6 | 2025-06-05

US20250179048A1

Chemistry; metallurgy

POLYMORPHS OF [2-(1H-INDOL-3-YL)-1H-IMIDAZOL-4-YL](3,4,5-TRIMETHOXYPHENYL)METHANONE AND ITS SALTS

#7 | 2025-05-29

US20250170091A1

Human necessities

USES OF SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) COMPOUNDS IN CHRONIC WEIGHT MANAGEMENT

#8 | 2024-06-06

US20240180879A1

Human necessities

METHODS OF TREATING INFLAMMATION

#9 | 2023-11-02

US20230348433A1

Chemistry; metallurgy

Polymorphs of [2-(1H-indol-3-yl)-1H-imidazol-4- yl] (3,4,5-trimethoxyphenyl)methanone and its salts

#10 | 2023-10-12

US20230321045A1

Human necessities

METHODS OF TREATING INFLUENZA AND POXVIRUS VIRAL INFECTIONS

#11 | 2023-08-24

US20230265081A1

Chemistry; metallurgy

METHODS OF TREATING CORONAVIRUS

#12 | 2023-06-08

US20230172897A1

Human necessities

METHODS OF TREATING BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS AND ADDITIONAL THERAPEUTIC AGENTS

#13 | 2022-08-18

US20220257552A1

Human necessities

METHODS OF PRESCREENING AND TREATING BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS

#14 | 2021-10-07

US20210308105A1

Human necessities

Methods of treating coronavirus

#15 | 2021-07-29

US20210228529A1

Human necessities

PHARMACEUTICAL COMPOSITIONS FOR TREATING BREAST CANCERS AND METHODS OF USES THEREOF

#16 | 2021-05-06

US20210128513A1

Human necessities

Treatment of skeletal-related events for breast cancer patients

#17 | 2020-09-10

US20200282008A1

Human necessities

COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS

#18 | 2019-12-26

US20190389841A1

Chemistry; metallurgy

COMPOUNDS FOR TREATMENT OF TRIPLE NEGATIVE BREAST CANCER AND OVARIAN CANCER

#19 | 2019-05-02

US20190125716A1

Human necessities

Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy

#20 | 2018-09-06

US20180250354A1

Human necessities

COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS

#21 | 2018-08-02

US20180214507A1

Human necessities

COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS

#22 | 2017-07-27

US20170209407A1

Human necessities

Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)

#23 | 2017-01-12

US20170007567A1

Human necessities

Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)

#24 | 2016-05-12

US20160128968A1

Human necessities

Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)

#25 | 2015-03-26

US20150087712A1

Chemistry; metallurgy

Estrogen receptor ligands and methods of use thereof

#26 | 2014-11-27

US20140350102A1

Chemistry; metallurgy

Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)

#27 | 2014-07-03

US20140187641A1

Chemistry; metallurgy

ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF

#28 | 2014-06-19

US20140171468A1

Chemistry; metallurgy

Estrogen receptor ligands and methods of use thereof

#29 | 2014-05-15

US20140134274A1

Human necessities

Selective androgen receptor modulator for treating hormone-related conditions

#30 | 2014-03-20

US20140080905A1

Chemistry; metallurgy

Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)

#31 | 2014-02-27

US20140057985A1

Chemistry; metallurgy

ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF

#32 | 2014-01-16

US20140018433A1

Chemistry; metallurgy

Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)

#33 | 2014-01-09

US20140011774A1

Human necessities

SELECTIVE ANDROGEN RECEPTOR MODULATORS

#34 | 2012-03-29

US20120077845A1

Human necessities

Estrogen receptor ligands and methods of use thereof

#35 | 2011-09-29

US20110237664A1

Human necessities

SELECTIVE ANDROGEN RECEPTOR MODULATORS FOR TREATING DIABETES

#36 | 2011-04-07

US20110082212A1

Chemistry; metallurgy

MULTI-SUBSTITUTED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF

#37 | 2010-11-04

US20100280107A1

Human necessities

Treating benign prostate hyperplasia with SARMS

#38 | 2010-10-21

US20100267773A1

Chemistry; metallurgy

Estrogen receptor ligands and methods of use thereof

#39 | 2010-08-17

US10359270

Treating benign prostate hyperplasia with SARMS

#40 | 2010-06-10

US20100144871A1

Human necessities

Treating muscle wasting with selective androgen receptor modulators

#41 | 2009-06-16

US10310150

Treating muscle wasting with selective androgen receptor modulators

#42 | 2009-04-28

US10778334

Prevention and treatment of androgen—deprivation induced osteoporosis

#43 | 2008-10-09

US20080249183A1

Human necessities

Treatment of androgen-deprivation induced osteoporosis

#44 | 2008-06-19

US20080145347A1

Chemistry; metallurgy

p-Hyde sequences in the Rat

#45 | 2007-08-23

US20070197664A1

Human necessities

Prevention and treatment of androgen-deprivation induced osteoporosis

#46 | 2007-06-14

US20070135407A1

Human necessities

Serm reduction of lipid profiles

#47 | 2006-12-21

US20060287400A1

Human necessities

Method for treatment and chemoprevention of prostate cancer

#48 | 2006-12-21

US20060287282A1

Human necessities

Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof

#49 | 2006-12-07

US20060276539A1

Human necessities

Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS

#50 | 2006-11-30

US20060270641A1

Human necessities

Method for chemoprevention of prostate cancer

#51 | 2006-11-30

US20060269611A1

Human necessities

Prevention and treatment of androgen-deprivation induced osteoporosis

#52 | 2006-11-16

US20060258628A1

Human necessities

Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof

#53 | 2006-08-17

US20060183931A1

Chemistry; metallurgy

Multi-substituted selective androgen receptor modulators and methods of use thereof

#54 | 2006-05-25

US20060111441A1

Human necessities

Treating wasting disorders with selective androgen receptor modulators

#55 | 2006-04-11

US10371213

Halogenated selective androgen receptor modulators and methods of use thereof

#56 | 2006-02-16

US20060035966A1

Chemistry; metallurgy

Irreversible selective androgen receptor modulators and methods of use thereof

#57 | 2006-01-26

US20060019989A1

Human necessities

Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof

#58 | 2006-01-12

US20060009488A1

Chemistry; metallurgy

Prodrugs of selective androgen receptor modulators and methods of use thereof

#59 | 2005-09-22

US20050209320A1

Chemistry; metallurgy

Anti-cancer compounds and methods of use thereof

#60 | 2005-08-04

US20050171073A1

Human necessities

Composition and method for treatment and chemoprevention of prostate cancer

#61 | 2005-05-31

US10305363

Prevention and treatment of androgen-deprivation induced osteoporosis

#62 | 2005-04-14

US20050080143A1

Human necessities

Treatment of androgen-deprivation induced osteoporosis

#63 | 2005-04-14

US20050080055A1

Human necessities

Method of treating breast cancer with androgen receptor antagonists

#64 | 2005-04-14

US20050080054A1

Chemistry; metallurgy

Treating androgen decline in aging male (ADAM)-associated conditions with SARMS

#65 | 2005-02-17

US20050038110A1

Chemistry; metallurgy

Selective androgen receptor modulators and methods of use thereof

#66 | 2005-02-10

US20050033074A1

Chemistry; metallurgy

Multi-substitued selective androgen receptor modulators and methods of use thereof

#67 | 2005-02-10

US20050032750A1

Human necessities

Treating androgen deficiency in female (ADIF)-associated conditions with SARMS

#68 | 2005-01-04

US10270232

Formulations comprising selective androgen receptor modulators

InventorID:

606357 ⎘